Por favor, use este identificador para citar o enlazar este ítem:
http://hdl.handle.net/10637/10822
Registro completo de metadatos
Campo DC | Valor | Lengua/Idioma |
---|---|---|
dc.creator | Rangasamy, Loganathan | - |
dc.creator | Pascual-Teresa Fernández, Beatriz de | - |
dc.creator | Zapico Rodríguez, José María | - |
dc.creator | Ramos González, Ana | - |
dc.creator | Ortín Remón, Irene | - |
dc.creator | Coderch Boué, Claire | - |
dc.date | 2020 | - |
dc.date.accessioned | 2020-06-09T04:00:17Z | - |
dc.date.available | 2020-06-09T04:00:17Z | - |
dc.date.issued | 2020-06-09 | - |
dc.identifier | 000000717528 | - |
dc.identifier.uri | http://hdl.handle.net/10637/10822 | - |
dc.description | ACS Medicinal Chemistry Letters, ISSN 1948-5875, 2020, 11, 5, 713-719. | - |
dc.description.abstract | Four potent CK2 inhibitors derived from CX-4945 are described. They are provided also of nanomolar activity against HDAC1, therefore having promising utility as dual-target agents for cancer. The linker length between the hydroxamic acid and the CX-4945 scaffold plays an important role in dictating balanced activity against the targeted enzymes. The seven-carbon linker (compound 15c) was optimal for inhibition of both CK2 and HDAC1. Remarkably, 15c showed 3.0 and 3.5 times higher inhibitory activity than the reference compounds CX-4945 (against CK2) and SAHA (against HDAC1), respectively. Compound 15c exhibited micromolar activity in cell-based cytotoxic assays against multiple cell lines. | en |
dc.format | application/pdf | - |
dc.language.iso | en | - |
dc.relation | Financiado con cargo a proyectos del Ministerio (MICIU/FEDER, UE grant number RTI2018-093539-B-I00) y de la Unión Europea (European Union?s Horizon 2020 research and innovation pro-gramme under the Marie-Sklodowska-Curie grant agreement number DUALITY 746225). | es |
dc.rights | http://creativecommons.org/licenses/by-nc-nd/4.0/deed.es | - |
dc.subject | Dinámica molecular. | - |
dc.subject | Drogas de objetivos múltiples. | es |
dc.subject | Multi-target drugs. | en |
dc.subject | Dual inhibitors. | en |
dc.title | New Dual CK2/HDAC1 Inhibitors with Nanomolar Inhibitory Activity against Both Enzymes. | - |
dc.type | Artículo | - |
dc.description.version | Post-print | en |
dc.identifier.doi | 10.1021/acsmedchemlett.9b00561 | - |
dc.centro | Universidad San Pablo-CEU | - |
Aparece en las colecciones: | Facultad de Farmacia |
Los ítems de DSpace están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.